Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.

Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in ...

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

As people age, so do their stem cells. Scientists have known for years that the stem cells that go on to become blood cells ...

Child welfare officials have taken temporary custody of an 11-year-old Ontario boy to ensure he undergoes chemotherapy after his father decided to take him off treatment for his aggressive form of ...

Rice University's Synthesis X Center and Houston Methodist Neal Cancer Center have awarded $90,000 in seed grants as part of a new strategic collaboration.

Learn more about whether Syndax Pharmaceuticals, Inc. or Vericel Corporation is a better investment based on AAII's A+ ...

Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

Learn more CoreCap Advisors moved in the opposite direction, reporting a new 690-share SLS position valued at about $10,180.

Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days ...